CD79A and HIV infectious disease: The magnitude, progression, and persistence of anti-SARS-CoV-2 IgM, IgG, and IgA antibodies, as well as neutralization strength, appear to be consistent in PLWH who have well-managed HIV infection (15, 46, 47).